Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer: A Clinical Commentary

被引：3
作者：
Stein, Cy A. [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
来源：
CLINICAL GENITOURINARY CANCER | 2015年 / 13卷 / 05期
关键词：
ACTIVE ANDROGEN RECEPTOR; ABIRATERONE ACETATE; ENZALUTAMIDE; DOCETAXEL; THERAPY; CABAZITAXEL; MEN;
D O I：
10.1016/j.clgc.2015.05.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：407 / 409
页数：3
相关论文
共 17 条
[1]  
Al Nakouzi N., 2014, Eur. Urol
[2]   AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Wang, Hao ;
Luber, Brandon ;
Nakazawa, Mary ;
Roeser, Jeffrey C. ;
Chen, Yan ;
Mohammad, Tabrez A. ;
Chen, Yidong ;
Fedor, Helen L. ;
Lotan, Tamara L. ;
Zheng, Qizhi ;
De Marzo, Angelo M. ;
Isaacs, John T. ;
Isaacs, William B. ;
Nadal, Rosa ;
Paller, Channing J. ;
Denmeade, Samuel R. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038
[3]   Efficacy of Enzalutamide Following Abiraterone Acetate in Chemotherapy- naive Metastatic Castration-resistant Prostate Cancer Patients [J].
Azad, Arun A. ;
Eigl, Bernhard J. ;
Murray, R. Nevin ;
Kollmannsberger, Christian ;
Chi, Kim N. .
EUROPEAN UROLOGY, 2015, 67 (01) :23-29
[4]   Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].
de Bono, Johann Sebastian ;
Oudard, Stephane ;
Ozguroglu, Mustafa ;
Hansen, Steinbjorn ;
Machiels, Jean-Pascal ;
Kocak, Ivo ;
Gravis, Gwenaelle ;
Bodrogi, Istvan ;
Mackenzie, Mary J. ;
Shen, Liji ;
Roessner, Martin ;
Gupta, Sunil ;
Sartor, A. Oliver .
LANCET, 2010, 376 (9747) :1147-1154
[5]   Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance [J].
Dehm, Scott M. ;
Schmidt, Lucy J. ;
Heemers, Hannelore V. ;
Vessella, Robert L. ;
Tindall, Donald J. .
CANCER RESEARCH, 2008, 68 (13) :5469-5477
[6]   Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer [J].
Efstathiou, Eleni ;
Titus, Mark ;
Wen, Sijin ;
Hoang, Anh ;
Karlou, Maria ;
Ashe, Robynne ;
Tu, Shi Ming ;
Aparicio, Ana ;
Troncoso, Patricia ;
Mohler, James ;
Logothetis, Christopher J. .
EUROPEAN UROLOGY, 2015, 67 (01) :53-60
[7]   Toward Predictive Signatures of Enzalutamide Response and Resistance [J].
Gleave, Martin ;
Chi, Kim .
EUROPEAN UROLOGY, 2015, 67 (01) :61-63
[8]   A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth [J].
Guo, Zhiyong ;
Yang, Xi ;
Sun, Feng ;
Jiang, Richeng ;
Linn, Douglas E. ;
Chen, Hege ;
Chen, Hegang ;
Kong, Xiangtian ;
Melamed, Jonathan ;
Tepper, Clifford G. ;
Kung, Hsing-Jien ;
Brodie, Angela M. H. ;
Edwards, Joanne ;
Qiu, Yun .
CANCER RESEARCH, 2009, 69 (06) :2305-2313
[9]   Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer [J].
Hu, Rong ;
Dunn, Thomas A. ;
Wei, Shuanzeng ;
Isharwal, Sumit ;
Veltri, Robert W. ;
Humphreys, Elizabeth ;
Han, Misop ;
Partin, Alan W. ;
Vessella, Robert L. ;
Isaacs, William B. ;
Bova, G. Steven ;
Luo, Jun .
CANCER RESEARCH, 2009, 69 (01) :16-22
[10]   Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100) [J].
Loriot, Y. ;
Bianchini, D. ;
Ileana, E. ;
Sandhu, S. ;
Patrikidou, A. ;
Pezaro, C. ;
Albiges, L. ;
Attard, G. ;
Fizazi, K. ;
De Bono, J. S. ;
Massard, C. .
ANNALS OF ONCOLOGY, 2013, 24 (07) :1807-1812
12